Author:
Capstick Rory A.,Whomble David,Orsi Douglas L.,Felts Andrew S.,Rodriguez Alice L.,Vinson Paige N.,Chang Sichen,Blobaum Anna L.,Niswender Colleen M.,Conn P. Jeffrey,Jones Carrie K.,Lindsley Craig W.,Han Changho
Funder
Vanderbilt Institute of Chemical Biology, School of Medicine, Vanderbilt University
Vanderbilt-Ingram Cancer Center
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference17 articles.
1. Muscarinic acetylcholine receptor subtypes as potential drug targets for the treatment of schizophrenia, drug abuse, and Parkinson’s Disease;Dencker;ACS Chem Neurosci,2012
2. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors;Caulfield;Pharmacol Rev,1998
3. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia;Weiner;PNAS,1990
4. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain;Yasuda;Mol Pharmacol,1993
5. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia;Basile;PNAS,2002
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献